Fatal hepatic failure with liposomal doxorubicin

Lancet. 1993 Feb 6;341(8841):383-4. doi: 10.1016/0140-6736(93)90198-p.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Adult
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects*
  • Drug Carriers
  • Hepatic Encephalopathy / chemically induced*
  • Humans
  • Liposomes
  • Male
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / etiology

Substances

  • Drug Carriers
  • Liposomes
  • Doxorubicin